Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Comments for:

Dishonesty in scientific research
Nina Mazar, Dan Ariely
Nina Mazar, Dan Ariely
Published November 2, 2015
Citation Information: J Clin Invest. 2015;125(11):3993-3996. https://doi.org/10.1172/JCI84722.
View: Text | PDF
Op-Ed Article has an altmetric score of 53

Dishonesty in scientific research

  • Text
  • PDF
Abstract

Fraudulent business practices, such as those leading to the Enron scandal and the conviction of Bernard Madoff, evoke a strong sense of public outrage. But fraudulent or dishonest actions are not exclusive to the realm of big corporations or to evil individuals without consciences. Dishonest actions are all too prevalent in everyone’s daily lives, because people are constantly encountering situations in which they can gain advantages by cutting corners. Whether it’s adding a few dollars in value to the stolen items reported on an insurance claim form or dropping outlier data points from a figure to make a paper sound more interesting, dishonesty is part of the human condition. Here, we explore how people rationalize dishonesty, the implications for scientific research, and what can be done to foster a culture of research integrity.

Authors

Nina Mazar, Dan Ariely

×

Dishonesty in scientific research

Submitter: Shashi Seshia | sseshia@yahoo.ca

University of Saskatchewan, 107, Hospital Drive, Saskatoon, Saskatchewan, S7N 0W8, Canada

Published December 7, 2015

Mazar & Ariely’s paper (1) is of crucial relevance in the efforts to improve the quality of evidence that informs healthcare; our recent publications complement their message (2, 3). We need to reclaim the integrity, dedication and code of honor Sir Austin Bradford Hill considered essential to the practice of Medicine (4, 5), otherwise patients will continue to be placed at risk (6). Mazar & Ariely provide some urgently needed suggestions for reforms. 
References
1. Mazar N, Ariely D. Dishonesty in scientific research. J Clin Invest. 2015;125(11):3993-3996.
2. Seshia SS, Makhinson M, Phillips DF, Young GB. Evidence-informed person-centered healthcare part I: Do 'cognitive biases plus' at organizational levels influence quality of evidence? J Eval Clin Pract. 2014;20(6):734-747.
3. Seshia SS, Makhinson M, Young GB. 'Cognitive biases plus': Covert subverters of healthcare evidence. Evid Based Med. 2015,Nov.26. doi: 10.1136/ebmed-2015-110302. Epub ahead of print].
4. Hill AB. Medical ethics and controlled trials. Br Med J. 1963;1(5337):1043-1049.
5. Seshia SS, Young GB. The evidence-based medicine paradigm: Where are we 20 years later? part 2. Can J Neurol Sci. 2013;40(4):475-481.
6. Seshia SS, Makhinson M, Young GB. Evidence-informed person-centred health care (part II): Are 'cognitive biases plus' underlying the EBM paradigm responsible for undermining the quality of evidence? J Eval Clin Pract. 2014;20(6):748-758.

 

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Blogged by 1
Referenced in 1 policy sources
Posted by 48 X users
On 2 Facebook pages
95 readers on Mendeley
See more details